inotrem raised €39M in a Series B round in Oct 2019. The company is based in Paris, France. Investors in the round: Invus, Morningside Group. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €39M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.